CICoR's research focus is small molecule research, antibody engineering, new modalities and technologies, spanning predominantly across the disease areas of Immunology and Oncology.

CICoR is further building up and accelerating its early clinical development capabilities. It benefits from and contributes to the local innovation ecosystem, while being empowered to discover and deliver life-changing medical treatments to patients in China and around the world.